A startup company called Foundation Medicine plans to develop a lab test for doctors to analyze patient cancer samples, to determine the genetic mutations that lead to cancer, which could guide doctors in choosing the best treatment options for their patients, according to MIT's Technology Review. "As a start, the test would focus on 100 genes that have been shown scientifically to play a role in cancer treatment and progression," the Review's Courtney Humphries writes.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

In a statement, National Institutes of Health Director Francis Collins says sexual harassment is "morally indefensible" and "unacceptable."

Octopuses might owe their intelligence to their liberal alterations to their genes, Cosmos reports.

Stat News and ProPublica report that African Americans are underrepresented in cancer clinical trials.

In Cell this week: genomic analysis of abdominal aortic aneurysm, effect of probiotics on the microbiome, and more.